90% MIT Extract Powder: Product Label vs Current COA Result
Catalog checkpoint: August 26, 2026.
“MIT 90% Mitragynine Extract Powder” is the current Kratom Paradise product-line name. The linked PharmLabs San Diego report contains a separate 87.01% mitragynine result for identified concentrate sample DD00126B(15). The 90% label and 87.01% analytical result are different fields, not a contradiction.
The retail and bulk listings point to sample ID SD260715-011 (142956), reported July 20, 2026. Reading the label beside the complete COA makes it possible to see exactly what was measured, what was not detected under the method, and where the result stops.
Product label and COA result side by side
| Field | Current value | Scope |
|---|---|---|
| Product-line name | MIT 90% Mitragynine Extract Powder | Retail catalog identity |
| Submitted sample | DD00126B(15) | Name printed on the linked report |
| Sample ID | SD260715-011 (142956) | Laboratory and accession identifiers |
| Mitragynine result | 87.01% (870.12mg/g) | Measured result for the submitted concentrate sample |
| Speciociliatine result | 9.08% (90.79mg/g) | Separate analyte result for the sample |
| 7-OH result | Not detected; LOQ 0.025ppm | Method-limited result for the sample |
| MGM-15 result | Not detected; LOQ 0.562ppm | Method-limited result for the sample |
| Report date | July 20, 2026 | Date printed on the document |
Why a product-line percentage can differ from a sample result
A product-line name organizes a catalog. A COA reports the laboratory’s finding for the material that was actually submitted. Natural and manufactured materials can vary, and analytical methods have their own uncertainty and reporting conventions. The clean presentation is therefore: 90% product line, 87.01% mitragynine for sample DD00126B(15).
Changing the title to 87.01% would erase the catalog identity. Calling the sample an exact 90.00% result would erase the laboratory finding. Keeping both numbers visible preserves the product record and the analytical record.
What “not detected” means for 7-OH and MGM-15
The COA lists 7-hydroxymitragynine and MGM-15 as not detected for the submitted sample. ND means the laboratory did not detect the analyte under the stated method and reporting limits. It is not the same as mathematical zero, and it does not retest every pouch or future lot.
The distinction became especially important on August 26, when DEA temporarily placed MGM-15, MGM-16, and mitragynine pseudoindoxyl in Schedule I. A sample-specific ND result is useful evidence about the submitted concentrate; it is not a federal legal certificate. Follow the DEA 7-OH Scheduling Tracker for the controlling document and effective dates.
Current standard and bulk weight lanes
Current sizes, prices, availability, and per-gram comparisons appear on the standard powder listing and bulk powder listing. Keeping changeable commerce data on the live product records prevents an older price ladder from being mistaken for today's offer.
Both listings are currently unflavored and point to the same report. That shared link indicates a common document reference; it does not mean every packaged weight received a separate laboratory test.
What the COA can support
- The identified submitted material was a concentrate sample named DD00126B(15).
- The report identifies sample ID SD260715-011 and accession reference 142956.
- The laboratory reported 87.01% mitragynine and 9.08% speciociliatine for that sample.
- 7-OH and MGM-15 were ND under the stated method and limits for that sample.
- The report date is July 20, 2026.
It cannot by itself establish the composition of later material, every packaged unit, a person’s response after consuming the powder, or a legal conclusion for a destination.
Why the result is not a 7-OH or tablet conversion
The report uses percent and milligrams per gram for a concentrate sample. The current tablet report uses milligrams per finished unit. Those units describe different matrices. Dividing a tablet label by the powder percentage would create an amount that the product records never state.
Mitragynine is psychoactive and can produce opioid-like effects, tolerance, dependence, or withdrawal. The powder’s analytical strength does not predict an effect-equivalent amount for 7-OH, which has different receptor potency. Read Can You Convert 7-OH Milligrams to MIT? before treating label values as a substitution chart.
How to save an auditable product record
- Record the complete product-line name and whether the listing is standard or bulk.
- Record the selected net weight, live price, and order date.
- Save the submitted sample name, sample ID, accession reference, and report date.
- Keep analyte results attached to their units, LOD, and LOQ.
- Retain the package label and direct document link with the order record.
The How to Read a Kratom Lab Report page walks through the document fields. The MIT Product Documents & COA Center provides the current product-to-document relationships.
Keeping that dated record also makes a later COA change visible instead of silently attaching new laboratory data to an older purchase.
Open the current MIT 90% listings
Choose the standard or bulk lane by net weight, then verify the current price and destination. Keep the 90% product-line identity and the 87.01% sample result together without rewriting one as the other.
Compare current MIT 90% powder weights
Check the current powder records
Open the standard MIT 90% powder listing or bulk MIT 90% powder listing for current sizes, price, availability, and the complete report link. Keep the 90% product-line label attached to the separately reported 87.01% result for sample DD00126B(15).
Official sources
- DEA temporary Schedule I order for MGPI, MGM-15, and MGM-16
- FDA information on concentrated 7-OH products
- FDA and Kratom
Featured image credit: Laboratory photograph by Julia Koblitz / Unsplash.
Product-label, laboratory-document, and regulatory information only; no medical, serving, withdrawal, equivalency, or legal advice.
